Vimarsana
Biggest News Aggregation in the World

Early Warrant Exercise Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Early Warrant Exercise Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Early Warrant Exercise Program Today - Breaking & Trending Today

Antibe Extends Early Warrant Exercise Incentive Program - Vimarsana News

Antibe Extends Early Warrant Exercise Incentive Program

TORONTO--(BUSINESS WIRE)--$ATBPF--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is extending the Early Warrant Exercise Incentive Program (“Early Warrant Exercise Program”) for...

Antibe Announces Early Warrant Exercise Incentive Program - Vimarsana News

Antibe Announces Early Warrant Exercise Incentive Program

TORONTO--(BUSINESS WIRE)--Dec 29, 2023--

First Hydrogen Pursues Quebec's Integration By Joining Hydrogène Quebec - Vimarsana News

First Hydrogen Pursues Quebec's Integration By Joining Hydrogène Quebec

Vancouver, British Columbia-- First Hydrogen Corp. ("FIRST HYDROGEN" or the "Company") proudly announces that it has joined Hydrogène Quebec as a founding

Defence Therapeutics Inc.: Defence Announces Additional and Final Exercises of Warrants for Gross Proceeds of Over $2.3 Million - Vimarsana News

Defence Therapeutics Inc.: Defence Announces Additional and Final Exercises of Warrants for Gross Proceeds of Over $2.3 Million

Vancouver, British Columbia--(Newsfile Corp. - May 26, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized

BioNxt Solutions Inc.: BioNxt Solutions Closes First Tranche of Financing - Vimarsana News

BioNxt Solutions Inc.: BioNxt Solutions Closes First Tranche of Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / March 27, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT)